Igor Proscurshim

Igor Proscurshim

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / General Surgery
AD Scientific Index ID: 4405117
武田薬品工業株式会社
person_outline Igor Proscurshim's MOST POPULAR ARTICLES
1-) Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease controlA Habr-Gama, J Gama-Rodrigues, GP São Julião, I Proscurshim, ...International Journal of Radiation Oncology* Biology* Physics 88 (4), 822-828, 20145462014
2-) Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer managementA Habr-Gama, J Sabbaga, J Gama-Rodrigues, GP Sao Juliao, ...Dis Colon Rectum 56, 1109-1117, 20134562013
3-) Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapyA Habr-Gama, RO Perez, I Proscurshim, FG Campos, W Nadalin, D Kiss, ...Journal of gastrointestinal surgery 10 (10), 1319-1329, 20064142006
4-) Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome?A Habr-Gama, RO Perez, I Proscurshim, RMN Dos Santos, D Kiss, ...International Journal of Radiation Oncology* Biology* Physics 71 (4), 1181-1188, 20082702008
5-) Loop ileostomy morbidity: timing of closure mattersRO Perez, A Habr-Gama, VE Seid, I Proscurshim, AH Sousa, DR Kiss, ...Diseases of the colon & rectum 49, 1539-1545, 20062062006